Literature DB >> 18418318

Peripheral neuropathies associated with monoclonal gammopathies of undetermined significance.

John J Kelly1.   

Abstract

Monoclonal gammopathies (MGs) or plasma cell dyscrasias (PCDs) are hematologic disorders that may affect peripheral nerves. An MG is a proliferation of a single clone of neoplastic or nonneoplastic plasma that usually secretes a monoclonal protein (M-protein) serum or urine. If a diagnosis of monoclonal gammopathy of undetermined significance (MGUS) is established, a sudden increase in M-protein levels can indicate malignant transformation of a benign PCD. Roughly 50% of MGUS neuropathies are associated with an IgM gammopathy and the remaining 50% with IgG- and IgA-MGUS-associated neuropathies. MGUS is the most common of the PCDs associated with neurologic disorders, which are easily approached clinically by classifying them as IgM or non-IgM types.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418318

Source DB:  PubMed          Journal:  Rev Neurol Dis        ISSN: 1545-2913


  6 in total

1.  Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor.

Authors:  Carlo Canepa
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.

Authors:  Mohamed M El-Difrawy; Nadia E Zaki; Hazem M Marouf; Mona W Ayad; Ahmed M Farag
Journal:  Int J Hematol       Date:  2011-12-17       Impact factor: 2.490

3.  Pathogenesis and Treatment of Anti-MAG Neuropathy.

Authors:  Marinos C Dalakas
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

Review 4.  An update on monoclonal gammopathy and neuropathy.

Authors:  Sindhu Ramchandren; Richard A Lewis
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 5.  The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy.

Authors:  Toshio Ariga
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 6.  Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2018-01-15       Impact factor: 6.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.